Consolidated Statements of Stockholders' Equity - USD ($)	Convertible Preferred Stock [Member] Preferred Stock [Member]	Convertible Preferred Stock [Member] Common Stock [Member]	Convertible Preferred Stock [Member]	Series D Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member]	Series C Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Additional Paid-in Capital [Member]	Series C Preferred Stock [Member]	Series B Preferred Stock [Member] Preferred Stock [Member]	Series B Preferred Stock [Member] Additional Paid-in Capital [Member]	Series B Preferred Stock [Member]	Series A Preferred Stock [Member] Preferred Stock [Member]	Series A Preferred Stock [Member] Additional Paid-in Capital [Member]	Series A Preferred Stock [Member]	Conversion of Accounts Payable to Convertible Preferred Stock [Member] Preferred Stock [Member]	Conversion of Accounts Payable to Convertible Preferred Stock [Member]	Conversion from Series A Preferred Stock to Common Stock [Member] Preferred Stock [Member]	Conversion from Series A Preferred Stock to Common Stock [Member] Common Stock [Member]	Conversion from Series A Preferred Stock to Common Stock [Member] Additional Paid-in Capital [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2019																					3,879,608				(43,658)
Balance at Dec. 31, 2019																					$ 13,898,494	$ 3,587,287	$ (9,992,841)	$ (5,348,812)	$ (160,784)	$ (856,837)	$ 1,126,507
Convertible Preferred Stock Issuance - cash (in shares)	542,660	400,000												42,660
Convertible Preferred Stock Issuance - cash	$ 5,093,267	$ 333,334	$ 5,426,601											$ 426,600							15,000
Conversion of Convertible Securities (in shares)															48,200		(90,860)	941,388
Conversion of Convertible Securities															$ 478,017	$ 478,017	$ (946,938)		$ 946,938
Common stock issued for placement agent fees																				$ (306,000)	$ 306,000
Common stock issued for placement agent fees (in shares)																					200,000
Warrants issued to placement agent and other issuance costs																				(919,105)		919,105
Common stock issued for warrants exercised - cashless (in shares)																					391,308						391,308
Stock Issued During Period, Value, New Issues	$ 5,093,267	$ 333,334	$ 5,426,601											426,600							$ 15,000
Placement agent fees and issuance costs																				(1,024,313)							$ (1,024,313)
Beneficial Conversion feature (BCF) on Preferred Stock										$ 1,500,000	$ 1,500,000	$ (2,468,473)	$ 2,468,473
Deemed Dividend on BCF of Preferred Stock										(1,500,000)	(1,500,000)	2,468,473	(2,468,473)
Accrued Deemed Dividend										(13,600)	(13,600)	$ 379,655	(379,655)	380,000
Accretion of Series B Preferred Stock																						(18,564)					(18,564)
Net Loss																							(4,434,759)				(4,434,759)
Net Income (Loss) Attributable to Noncontrolling Interest																										138,198	138,198
Net loss																											(4,296,561)
Foreign equity																							45,273			427	45,700
Foreign Currency Translation																								(536,300)			(536,300)
Balance (in shares) at Dec. 31, 2020												500,000								500,000	5,827,304				(43,658)
Balance at Dec. 31, 2020												$ 2,754,583								$ 2,754,583	$ 14,537,828	5,041,511	(14,382,327)	(5,885,112)	$ (160,784)	(718,212)	1,187,487
Convertible Preferred Stock Issuance - cash (in shares)				170,000		170,000			170,000
Convertible Preferred Stock Issuance - cash				$ 1,500,000	$ 1,500,000	$ 1,500,000		$ 1,500,000	$ 1,612,707		1,612,707
Common stock issued for warrants exercised - cashless (in shares)																					103,104
Stock Issued During Period, Value, New Issues				$ 1,500,000	$ 1,500,000	1,500,000		1,500,000	1,612,707		1,612,707
Deemed Dividend on BCF of Preferred Stock								$ (1,500,000)														(1,500,000)
Accrued Deemed Dividend						$ 130,333	$ (130,333)		$ 102,000	$ (135,611)	(33,611)	$ 400,000	$ (400,000)	$ 400,000
Accretion of Series B Preferred Stock											$ (46,932)											(46,932)
Net Loss																											(8,272,517)
Net Income (Loss) Attributable to Noncontrolling Interest																											718,212
Net loss																							(8,272,517)			$ 718,212	(7,554,305)
Foreign Currency Translation																								$ 5,885,112			5,885,112
BCF																						1,500,000					1,500,000
Balance (in shares) at Dec. 31, 2021				170,000		170,000			170,000			500,000									5,930,408				(43,658)
Balance at Dec. 31, 2021				$ 1,500,000		$ 1,630,333			$ 1,714,707			$ 3,154,583									$ 14,537,828	$ 4,328,635	$ (22,654,844)		$ (160,784)		$ 4,050,458